Cost estimation of medical care management of lung cancer in Tunisia.
East Mediterr Health J
; 24(10): 988-993, 2018 Dec 18.
Article
en En
| MEDLINE
| ID: mdl-30582141
ABSTRACT
BACKGROUND:
Lung cancer management is very expensive for the Tunisian healthcare system.AIM:
The aim of this study was to evaluate the direct costs of treating lung cancer in Tunisia, and to identify the main treatment of high expenditure.METHODS:
A retrospective study was conducted in 2012 including all patients admitted between 2008 and 2010 for lung cancer management. The hospital payment system was used to estimate the direct costs of the medical care management of lung cancer.RESULTS:
We collected 549 patients and the majority of patients were diagnosed with advanced stages of the disease 60 % in stage T4 and 59 % in stage M1. 26 % of patients underwent surgery and 44.1 % chemotherapy. The total direct costs of lung cancer management were estimated to be TND 3900 (US$ 1980) per patient.CONCLUSIONS:
Chemotherapy accounted for the largest percentage of direct costs (46 %) followed by the cost of the hospital stay. Primary prevention, based on the application of policies to control tobacco, is the best strategy to reduce this morbidity.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Gastos en Salud
/
Neoplasias Pulmonares
Tipo de estudio:
Health_economic_evaluation
/
Observational_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Africa
Idioma:
En
Revista:
East Mediterr Health J
Asunto de la revista:
MEDICINA
Año:
2018
Tipo del documento:
Article